Luc J Moens

Title: Luc J Moens: Innovator in Pharmaceutical Chemistry

Introduction

Luc J Moens is a notable inventor based in Lille, Belgium, recognized for his contributions to pharmaceutical chemistry. He holds three patents that reflect his expertise in the preparation of enantiomerically pure compounds. His work is significant in the field of medicinal chemistry, particularly in the development of new therapeutic agents.

Latest Patents

Luc J Moens' latest patents include a process for preparing enantiomerically pure imidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-thiones. This process starts from 2,6-dihalo-3-nitrobenzyl derivatives and suitably N-protected 1,2-diaminopropanes. The patents also detail the novel enantiomerically pure intermediates prepared during this process, which are crucial for advancing pharmaceutical applications.

Career Highlights

Throughout his career, Luc J Moens has made significant strides in the pharmaceutical industry. He is currently associated with Janssen Pharmaceutica NV, a leading company in the development of innovative medicines. His work has contributed to the advancement of therapeutic options available to patients.

Collaborations

Luc J Moens has collaborated with esteemed colleagues such as Alfons G De Knaep and Eduard J Vreysen. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Luc J Moens exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborations. His work continues to impact the field positively, paving the way for future advancements in medicine.